Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
17 Jul 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250715531249/en/Elix-Provides-AI-Drug-Discovery-Platform-Elix-Discovery-to-Eisai
22 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eisai-to-present-e7386-co-created-by-prism-biolab-and-eisai-at-the-asco-american-society-of-clinical-oncology-annual-meeting-302463001.html
20 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eisai-demonstrates-commitment-to-oncology-innovation-at-asco-2025-302459508.html
19 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/eisai-biogen-leqembi-first-fda-approved-alzheimers-blood-test-takes-time-benefit-launch
19 May 2025
// FIERCE PHARMA
https://www.fiercepharma.com/marketing/eisai-mounts-targeted-tv-ad-push-raise-awareness-leqembi
15 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/eisai-projects-leqembi-revenue-to-total-jpy-76-5-billion-for-fiscal-year-2025-april-2025--march-2026-302456441.html
Inspections and registrations
ABOUT THIS PAGE
Eisai is a supplier offers 18 products (APIs, Excipients or Intermediates).
Find a price of Azilsartan bulk with JDMF offered by Eisai
Find a price of Donepezil bulk with JDMF offered by Eisai
Find a price of Epalrestat bulk with JDMF offered by Eisai
Find a price of Eribulin bulk with JDMF offered by Eisai
Find a price of Fosravuconazole bulk with JDMF offered by Eisai
Find a price of Pranlukast Hydrate bulk with JDMF offered by Eisai
Find a price of Rabeprazole Sodium bulk with JDMF offered by Eisai
Find a price of Ramelteon bulk with JDMF offered by Eisai
Find a price of Teprenone bulk with JDMF offered by Eisai
Find a price of Bentiromide bulk offered by Eisai
Find a price of Eperisone bulk offered by Eisai
Find a price of Menfegol bulk offered by Eisai
Find a price of Donepezil bulk offered by Eisai
Find a price of Eribulin bulk offered by Eisai
Find a price of Lenvatinib Mesylate bulk offered by Eisai
Find a price of Perampanel bulk offered by Eisai
Find a price of Rabeprazole Sodium bulk offered by Eisai
Find a price of Teprenone bulk offered by Eisai